Peptidomimetic blockade of MYB in acute myeloid leukemiaKavitha Ramaswamy, Alex Kentsis|Nature Communications|2018Cited by 95
Prohibitin is a prognostic marker and therapeutic target to block chemotherapy resistance in Wilms’ tumorMichael V. Ortiz, Alex Kentsis|JCI Insight|2019Cited by 29
Peptidomimetic blockade of MYB in acute myeloid leukemiaKavitha Ramaswamy, Alex Kentsis|bioRxiv (Cold Spring Harbor Laboratory)|2017Cited by 11
KAT6A and KAT7 Histone Acetyltransferase Complexes Are Molecular Dependencies and Therapeutic Targets in <i>NUP98</i> -Rearranged Acute Myeloid LeukemiaNicole L. Michmerhuizen, Charles G. Mullighan, Yu Sun et al.|Cancer Discovery|2025Cited by 11
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemiaFiona C. Brown, Alex Kentsis|bioRxiv (Cold Spring Harbor Laboratory)|2017Cited by 8